Department of Anesthesiology, University of Minnesota, Minneapolis, MN.
University of Minnesota Medical School, Minneapolis, MN.
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3038-3046. doi: 10.1053/j.jvca.2022.03.017. Epub 2022 Mar 22.
Does point-of-care viscoelastic testing in patients undergoing left ventricular assist device implantation or orthotopic heart transplantation reduce non-red blood cell transfusion or improve postoperative outcomes?
A retrospective observational study.
At a single-center tertiary university hospital.
Patients undergoing left ventricular assist device placement or heart transplantation INTERVENTIONS: The authors implemented a TEG-based transfusion algorithm to reduce non-red cell transfusion rates compared with historical controls.
From May 15, 2019, through March 20, 2020, 68 patients underwent left ventricular assist device placement or heart transplantation. Algorithm adherence was 49.2%. After adjusting for relevant variables, platelet (odds ratio [OR] 0.58 [0.39-0.84]; p = 0.004) and cryoprecipitate (OR 0.37 [0.19-0.72]; p = 0.004) transfusion rates and time to extubation (OR -14.1 [-25.8 to -2.3]; p = 0.020) were significantly reduced compared with historical controls. After adjusting for relevant clinical variables, there was a statistically significant reduction in plasma (median [interquartile range] 0.16 [0.07-0.36], p < 0.001), platelets (0.06 [0.02-0.21], p < 0.001), and cryoprecipitate (0.06 [0.01-0.47], p = 0.007) transfusion rates and time to extubation (-16.95 [-27.20 to -6.71], p = 0.002) compared with historical controls.
The authors report a statistically significant reduction in transfusion of platelets and cryoprecipitate and time to extubation after adjusting for relevant clinical variables compared with historical controls and a significant reduction in the transfusion of plasma, platelets, and cryoprecipitate and time to extubation in those patients for whom the transfusion algorithm was followed. Their results suggest the importance of implementing transfusion algorithms for patients undergoing heart transplantation and left ventricular assist device placement and of accounting for adherence.
在接受左心室辅助装置植入或原位心脏移植的患者中进行即时弹性检测是否可以减少非红细胞输血或改善术后结局?
回顾性观察性研究。
单中心三级大学医院。
接受左心室辅助装置植入或心脏移植的患者。
作者实施了基于 TEG 的输血算法,与历史对照相比,降低了非红细胞输血率。
2019 年 5 月 15 日至 2020 年 3 月 20 日,68 例患者接受左心室辅助装置植入或心脏移植。算法的依从性为 49.2%。在调整相关变量后,血小板(比值比 [OR] 0.58 [0.39-0.84];p=0.004)和冷沉淀(OR 0.37 [0.19-0.72];p=0.004)的输血率和拔管时间(OR-14.1[-25.8 至-2.3];p=0.020)与历史对照相比显著降低。在调整相关临床变量后,与历史对照相比,血浆(中位数 [四分位数范围] 0.16 [0.07-0.36],p<0.001)、血小板(0.06 [0.02-0.21],p<0.001)和冷沉淀(0.06 [0.01-0.47],p=0.007)的输血率和拔管时间(-16.95[-27.20 至-6.71],p=0.002)均显著降低。
与历史对照相比,在调整相关临床变量后,作者报告血小板和冷沉淀输血率和拔管时间有统计学显著降低,与未遵循输血算法的患者相比,血浆、血小板和冷沉淀输血率和拔管时间有显著降低。结果表明,对于接受心脏移植和左心室辅助装置植入的患者,实施输血算法和考虑依从性非常重要。